Drug Cuts Albuminuria in Type 1 Diabetic Kidney Disease, Too

By News Health
57 minutes Ago

(MedPage Today) — Finerenone (Kerendia) significantly reduced albuminuria in adults with type 1 diabetes and chronic kidney disease (CKD), meeting the primary endpoint of the phase III FINE-ONE trial.
Over 6 months, the urinary albumin-to-creatinine…

Source link : https://www.medpagetoday.com/nephrology/type1diabetes/120166

Author :

Publish date : 2026-03-04 22:40:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

These ER Docs Are Being Ousted After 35 Years. They're Not Going Quietly.

Drug breakthrough for children with severe form of epilepsy

Rapid RSV Tests Can Cut Down on Unneeded Antibiotics, Study Suggests

Study Identifies Factors Linked to Early Melanoma Recurrence

Parkinson's Protein Linked to Faster Alzheimer's Progression in Women

Prolonged Amoxicillin Challenge Checks Penicillin Allergy